Connolly, D. ., Collins, E. ., Ren, H. ., Ming, W. Y., Davidson, J. ., & Bain, S. . (2025). Real-World Comparisons Between Glucagon-Like Peptide-1 Receptor Agonists and Other Glucose-Lowering Agents in Type 2 Diabetes: Retrospective Analyses of Cardiovascular and Economic Outcomes in England. Diabetes Ther. http://doi.org/10.1007/s13300-025-01715-w
diabetes
Alturkistani, A. ., Beaney, T. ., Greenfield, G. ., & Costelloe, C. E. (2025). Prescription Refill Adherence Before and After Patient Portal Registration in Among General Practice Patients in England Using the Clinical Practice Research Datalink: Longitudinal Observational Study. JMIR Med Inform, 13, e50294. http://doi.org/10.2196/50294
Panchal, K. ., Lawson, C. ., Shabnam, S. ., Khunti, K. ., & Zaccardi, F. . (2025). Incidence trends in ischaemic and non-ischaemic heart failure in people with and without type 2 diabetes, 2000-2019: An observational study in England. Diabetes Res Clin Pract, 220, 111980. http://doi.org/10.1016/j.diabres.2024.111980
Cook, S. ., Saxena, S. ., Mathur, R. ., Beaney, T. ., Gnani, S. ., Neves, A. L., … Quint, J. K. (2025). Diabetes complications in people with alcohol use disorder and type 2 diabetes. BJGP Open. http://doi.org/10.3399/bjgpo.2024.0133
Panchal, K. ., Lawson, C. ., Shabnam, S. ., Khunti, K. ., & Zaccardi, F. . (2024). Incidence trends in ischaemic and non-ischaemic heart failure in people with and without type 2 diabetes, 2000-2019: An observational study in England. Diabetes Res Clin Pract, 111980. http://doi.org/10.1016/j.diabres.2024.111980
Palladino, R. ., Chataway, J. ., Mathew, M. ., Majeed, A. ., & Marrie, R. A. (2024). Trajectories and management of vascular risk following the diagnosis of multiple sclerosis: A population-based matched cohort study between 1987 and 2018 in England. Mult Scler, 13524585241287388. http://doi.org/10.1177/13524585241287388
Cook, S. ., Osborn, D. ., Mathur, R. ., Forbes, H. ., Parekh, R. ., Maini, A. ., … Quint, J. K. (2024). Is alcohol use disorder associated with higher rates of depression and anxiety among people with new onset type 2 diabetes? A cohort study using linked primary care data in England. BMC Prim Care, 25, 386. http://doi.org/10.1186/s12875-024-02628-6
Eyles, E. ., Margelyte, R. ., Edwards, H. B., Moran, P. A., Kessler, D. S., Davies, S. J. C., … Sullivan, S. A. (2023). Antipsychotic Medication and Risk of Metabolic Disorders in People With Schizophrenia: A Longitudinal Study Using the UK Clinical Practice Research Datalink. Schizophr Bull. http://doi.org/10.1093/schbul/sbad126
Chudasama, Y. V., Khunti, K. ., Coles, B. ., Gillies, C. L., Islam, N. ., Rowlands, A. V., … Zaccardi, F. . (2023). Life expectancy following a cardiovascular event in individuals with and without type 2 diabetes: A UK multi-ethnic population-based observational study. Nutr Metab Cardiovasc Dis. http://doi.org/10.1016/j.numecd.2023.04.003
Cao, T. X. D., Filliter, C. ., Montastruc, F. ., H. Y. Yu, O. ., Fergusson, E. ., Rej, S. ., … Renoux, C. . (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231–237. http://doi.org/10.1016/j.jad.2022.08.094